277 related articles for article (PubMed ID: 1589858)
1. Treatment of metastatic uveal melanoma: review and recommendations.
Albert DM; Niffenegger AS; Willson JK
Surv Ophthalmol; 1992; 36(6):429-38. PubMed ID: 1589858
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of metastatic malignant uveal melanoma].
Jäckel A; Bock M; Deichmann M; Waldmann V; Näher H
Hautarzt; 2001 Feb; 52(2):98-103. PubMed ID: 11244899
[TBL] [Abstract][Full Text] [Related]
3. Uveal melanoma: natural history and treatment options for metastatic disease.
Wöll E; Bedikian A; Legha SS
Melanoma Res; 1999 Dec; 9(6):575-81. PubMed ID: 10661768
[TBL] [Abstract][Full Text] [Related]
4. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.
Becker JC; Terheyden P; Kämpgen E; Wagner S; Neumann C; Schadendorf D; Steinmann A; Wittenberg G; Lieb W; Bröcker EB
Br J Cancer; 2002 Oct; 87(8):840-5. PubMed ID: 12373596
[TBL] [Abstract][Full Text] [Related]
5. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
[TBL] [Abstract][Full Text] [Related]
6. Classical chemotherapy for metastatic melanoma.
Becker JC; Kämpgen E; Bröcker E
Clin Exp Dermatol; 2000 Sep; 25(6):503-8. PubMed ID: 11044186
[TBL] [Abstract][Full Text] [Related]
7. Systemic and liver-directed therapies in metastatic uveal melanoma: state-of-the-art and novel perspectives.
Comito F; Marchese PV; Ricci AD; Tober N; Peterle C; Sperandi F; Melotti B
Future Oncol; 2021 Nov; 17(33):4583-4606. PubMed ID: 34431316
[TBL] [Abstract][Full Text] [Related]
8. Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
Sacco JJ; Kalirai H; Kenyani J; Figueiredo CR; Coulson JM; Coupland SE
Future Oncol; 2018 Jun; 14(14):1335-1338. PubMed ID: 29741103
[No Abstract] [Full Text] [Related]
9. Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma.
Klemen ND; Wang M; Rubinstein JC; Olino K; Clune J; Ariyan S; Cha C; Weiss SA; Kluger HM; Sznol M
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32209601
[TBL] [Abstract][Full Text] [Related]
10. Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study.
Jespersen H; Olofsson Bagge R; Ullenhag G; Carneiro A; Helgadottir H; Ljuslinder I; Levin M; All-Eriksson C; Andersson B; Stierner U; Nilsson LM; Nilsson JA; Ny L
BMC Cancer; 2019 May; 19(1):415. PubMed ID: 31046743
[TBL] [Abstract][Full Text] [Related]
11. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma.
Niederkorn JY; Mellon J; Pidherney M; Mayhew E; Anand R
Curr Eye Res; 1993 Apr; 12(4):347-58. PubMed ID: 8319494
[TBL] [Abstract][Full Text] [Related]
12. Uveal melanoma.
Spagnolo F; Caltabiano G; Queirolo P
Cancer Treat Rev; 2012 Aug; 38(5):549-53. PubMed ID: 22270078
[TBL] [Abstract][Full Text] [Related]
13. Variates of survival in metastatic uveal melanoma.
Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma.
Neale MH; Myatt NE; Khoury GG; Weaver P; Lamont A; Hungerford JL; Kurbacher CM; Hall P; Corrie PG; Cree IA
Melanoma Res; 2001 Dec; 11(6):601-9. PubMed ID: 11725206
[TBL] [Abstract][Full Text] [Related]
15. Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
Niederkorn A; Wackernagel W; Artl M; Schwantzer G; Aigner B; Richtig E
Acta Ophthalmol; 2014 Dec; 92(8):e696-7. PubMed ID: 24774993
[No Abstract] [Full Text] [Related]
16. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives.
Buder K; Gesierich A; Gelbrich G; Goebeler M
Cancer Med; 2013 Oct; 2(5):674-86. PubMed ID: 24403233
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide.
Soni S; Lee DS; DiVito J; Bui AH; DeRaffele G; Radel E; Kaufman HL
J Pediatr Hematol Oncol; 2002; 24(6):488-91. PubMed ID: 12218599
[TBL] [Abstract][Full Text] [Related]
18. Metastatic disease from uveal melanoma: treatment options and future prospects.
Carvajal RD; Schwartz GK; Tezel T; Marr B; Francis JH; Nathan PD
Br J Ophthalmol; 2017 Jan; 101(1):38-44. PubMed ID: 27574175
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.
Algazi AP; Tsai KK; Shoushtari AN; Munhoz RR; Eroglu Z; Piulats JM; Ott PA; Johnson DB; Hwang J; Daud AI; Sosman JA; Carvajal RD; Chmielowski B; Postow MA; Weber JS; Sullivan RJ
Cancer; 2016 Nov; 122(21):3344-3353. PubMed ID: 27533448
[TBL] [Abstract][Full Text] [Related]
20. The treatment of metastatic uveal melanoma.
Pyrhönen S
Eur J Cancer; 1998 Jul; 34 Suppl 3():S27-30. PubMed ID: 9849406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
